196 related articles for article (PubMed ID: 14533004)
1. Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis.
Zhao X; Gharizadeh B; Hjelmström P; Pirskanen R; Nyrén P; Lefvert AK; Ghaderi M
Int J Mol Med; 2003 Nov; 12(5):749-53. PubMed ID: 14533004
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients.
Zheng B; Wiklund F; Gharizadeh B; Sadat M; Gambelunghe G; Hallmans G; Dillner J; Wallin KL; Ghaderi M
Anticancer Res; 2006; 26(5B):3669-74. PubMed ID: 17094383
[TBL] [Abstract][Full Text] [Related]
3. Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease.
Gambelunghe G; Ghaderi M; Gharizadeh B; Brozzetti A; Tortoioli C; Del Sindaco P; Sanjeevi CB; Hjelmström P; Sirsjö A; Nyren P; Santeusanio F; Falorni A
Eur J Immunogenet; 2004 Apr; 31(2):73-6. PubMed ID: 15086346
[TBL] [Abstract][Full Text] [Related]
4. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
[TBL] [Abstract][Full Text] [Related]
5. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese.
Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Jiang J; Wang Y; Zhang B; Liu M; Li Y
Chin Med J (Engl); 2001 Nov; 114(11):1162-6. PubMed ID: 11729511
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in CC chemokine receptors and hypertension.
Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
[TBL] [Abstract][Full Text] [Related]
7. [Distribution of HIV resistance CCR5-delta 32, CCR2-64 I and SDF1-3'A alleles and their polymorphisms in the Han population in China].
Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Shi M; Jiang J; Wang Y; Zhang B; Liu M; Li Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):256-60. PubMed ID: 11860793
[TBL] [Abstract][Full Text] [Related]
8. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
9. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications.
Yang B; Houlberg K; Millward A; Demaine A
Cytokine; 2004 May; 26(3):114-21. PubMed ID: 15135805
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction.
González P; Alvarez R; Batalla A; Reguero JR; Alvarez V; Astudillo A; Cubero GI; Cortina A; Coto E
Genes Immun; 2001 Jun; 2(4):191-5. PubMed ID: 11477473
[TBL] [Abstract][Full Text] [Related]
12. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
[TBL] [Abstract][Full Text] [Related]
13. CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease.
Galimberti D; Fenoglio C; Lovati C; Gatti A; Guidi I; Venturelli E; Cutter GR; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
J Neurol Sci; 2004 Oct; 225(1-2):79-83. PubMed ID: 15465089
[TBL] [Abstract][Full Text] [Related]
14. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
[TBL] [Abstract][Full Text] [Related]
15. Determination of the CCR2-64I/CCR5-59653T haplotype linkage disequilibrium in a sample of Polish population.
Lewandowska M; Trzeciak WH; Jagodzinski PP
Genetika; 2003 Jun; 39(6):831-3. PubMed ID: 12884524
[TBL] [Abstract][Full Text] [Related]
16. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
17. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease.
Huerta C; Alvarez V; Mata IF; Coto E; Ribacoba R; Martínez C; Blázquez M; Guisasola LM; Salvador C; Lahoz CH; Peña J
Neurosci Lett; 2004 Nov; 370(2-3):151-4. PubMed ID: 15488313
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis.
Soto-Sánchez J; Santos-Juanes J; Coto-Segura P; Coto E; Díaz M; Rodríguez I; Alvarez V
Cytokine; 2010 May; 50(2):114-6. PubMed ID: 20153665
[TBL] [Abstract][Full Text] [Related]
19. Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica.
Hisada M; Lal RB; Masciotra S; Rudolph DL; Martin MP; Carrington M; Wilks RJ; Manns A
J Infect Dis; 2002 May; 185(9):1351-4. PubMed ID: 12001056
[TBL] [Abstract][Full Text] [Related]
20. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus.
Aguilar F; Núñez-Roldán A; Torres B; Wichmann I; Sánchez-Román J; González-Escribano MF
J Rheumatol; 2003 Aug; 30(8):1770-4. PubMed ID: 12913933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
